Question 1

What is the catalog number for Lamin B2 (HRP)?

Accepted Answer

The catalog number for Lamin B2 (HRP) is L1227-14-HRP.

Question 2

What sizes are available for Lamin B2 (HRP)?

Accepted Answer

Lamin B2 (HRP) is available in the following size(s): 100 µL.

Question 3

Is Lamin B2 (HRP) in stock?

Accepted Answer

Lamin B2 (HRP) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 5

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 6

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Lamin B2 (HRP)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

LGR5/GPR49 Recombinant Antibody, AbBy Fluor™ 680 Conjugated

LGR5/GPR49 Recombinant Antibody, AbBy Fluor™ 680 Conjugated

NIT1 Mouse Monoclonal Antibody [Clone 4D12]

IL1R1, CT (IL1R1, IL1R, IL1RA, IL1RT1, Interleukin-1 receptor type 1, CD121 antigen-like family member A, Interleukin-1 receptor alpha, Interleukin-1 receptor type I, p80, CD121a, Interleukin-1 receptor type 1, membrane form, Interleukin-1 receptor type 1, soluble form) (FITC) discontinued

NFKB1 (Nuclear Factor NF-kappa-B p105 Subunit, p50, KBF1, p105, EBP-1, NF-kB1, NFKB-p50, NFkappaB, NF-kappaB, NFKB-p105, NF-kappa-B) discontinued

NFKB1 (Nuclear Factor NF-kappa-B p105 Subunit, p50, KBF1, p105, EBP-1, NF-kB1, NFKB-p50, NFkappaB, NF-kappaB, NFKB-p105, NF-kappa-B) discontinued